at Zacks.com (Jan 12, 2015)
Alere (ALR +1%) gets a lift from an upgrade to Outperform at Wedbush this morning, citing the company's progress in resolving its FDA issues around cardiology test manufacturing following yesterday's release of its 8-k.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 7, 2015)
at Benzinga.com (Jan 7, 2015)
at Zacks.com (Dec 11, 2014)
at Zacks.com (Oct 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs